Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Tickets start at $195, with passengers treated to free Sweetgreen salads and espresso martinis.
The stakes for media and tech companies have never been higher, even if attention spans have never been shorter.
The potential sale is playing out against a larger deal as Australian rival BHP has offered to buy parent Anglo American for $39 billion.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The company says a turnaround will take time as the market for luxury goods cools and China muddles through economic doldrums.
Despite Humane’s lofty dreams to disrupt the smartphone status quo, critics have not been thrilled with the startup’s debut device.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Moderna says it was willing to licence the tech but now wants to be repaid by rivals for vaccine revenue generated since then.
How tech firms reconcile their desire for endless growth with bold climate goals.
A new survey finds evidence that “the drugs have a meaningful impact on consumer behavior and spending on groceries and restaurants.”
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.